Works matching IS 00071048 AND DT 2018 AND VI 180 AND IP 4

Results: 25
    1
    2
    3
    4
    5
    6

    A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 4, p. 550, doi. 10.1111/bjh.15056
    By:
    • Sutton, Rosemary;
    • Venn, Nicola C.;
    • Law, Tamara;
    • Boer, Judith M.;
    • Trahair, Toby N.;
    • Ng, Anthea;
    • Den Boer, Monique L.;
    • Dissanayake, Anuruddhika;
    • Giles, Jodie E.;
    • Dalzell, Pauline;
    • Mayoh, Chelsea;
    • Barbaric, Draga;
    • Revesz, Tamas;
    • Alvaro, Frank;
    • Pieters, Rob;
    • Haber, Michelle;
    • Norris, Murray D.;
    • Schrappe, Martin;
    • Dalla Pozza, Luciano;
    • Marshall, Glenn M.
    Publication type:
    Article
    7
    8

    Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 4, p. 545, doi. 10.1111/bjh.15054
    By:
    • Reddy, Jay P.;
    • Hernandez, Mike;
    • Gunther, Jillian R.;
    • Dabaja, Bouthaina S.;
    • Martin, Geoffrey V.;
    • Jiang, Wen;
    • Akhtari, Mani;
    • Allen, Pamela K.;
    • Atkinson, Bradley J.;
    • Smith, Grace L.;
    • Pinnix, Chelsea C.;
    • Milgrom, Sarah A.;
    • Abou Yehia, Zeinab;
    • Osborne, Eleanor M.;
    • Oki, Yasuhiro;
    • Lee, Hun;
    • Hagemeister, Fredrick;
    • Fanale, Michelle A.
    Publication type:
    Article
    9
    10

    R‐CHOP <italic>versus</italic> dose‐adjusted R‐EPOCH in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 4, p. 534, doi. 10.1111/bjh.15051
    By:
    • Shah, Nirav N.;
    • Szabo, Aniko;
    • Huntington, Scott F.;
    • Epperla, Narendranath;
    • Reddy, Nishitha;
    • Ganguly, Siddhartha;
    • Vose, Julie;
    • Obiozor, Cynthia;
    • Faruqi, Fahad;
    • Kovach, Alexandra E.;
    • Costa, Luciano J.;
    • Xaiver, Ana C.;
    • Okal, Ryan;
    • Kanate, Abraham S.;
    • Ghosh, Nilanjan;
    • Kharfan‐Dabaja, Mohamed A.;
    • Strelec, Lauren;
    • Hamadani, Mehdi;
    • Fenske, Timothy S.;
    • Calzada, Oscar
    Publication type:
    Article
    11
    12
    13
    14
    15

    Issue Information.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 4, p. 463, doi. 10.1111/bjh.14928
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 4, p. 591, doi. 10.1111/bjh.14395
    By:
    • Thachil, Jecko;
    • Bagot, Catherine;
    • Bradbury, Charlotte;
    • Cooper, Nichola;
    • Lester, Will;
    • Grainger, John D.;
    • Lowe, Gillian;
    • Evans, Gillian;
    • Talks, Kate;
    • Sibson, Keith;
    • Garg, Mamta;
    • Murphy, Michael F.;
    • Watson, Henry G.;
    • Bolton‐Maggs, Paula H. B.;
    • Watson, Shirley;
    • Scully, Marie;
    • Provan, Drew;
    • Newland, Adrian;
    • Hill, Quentin A.
    Publication type:
    Article
    22
    23
    24

    Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 4, p. 581, doi. 10.1111/bjh.14388
    By:
    • Teramachi, Jumpei;
    • Hiasa, Masahiro;
    • Oda, Asuka;
    • Harada, Takeshi;
    • Nakamura, Shingen;
    • Amachi, Ryota;
    • Tenshin, Hirofumi;
    • Iwasa, Masami;
    • Fujii, Shiro;
    • Kagawa, Kumiko;
    • Miki, Hirokazu;
    • Kurahashi, Kiyoe;
    • Yoshida, Sumiko;
    • Endo, Itsuro;
    • Haneji, Tatsuji;
    • Matsumoto, Toshio;
    • Abe, Masahiro
    Publication type:
    Article
    25